ABL BIOTEC A/S: Financial statements 2013
CVR: 50811018
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -96,915 and a net result of DKK 2,724,804 compared with DKK 3,685,841 the year before. Equity in the 2013 report amounted to DKK 22,438,251. The solvency ratio was 99.3%.
- Gross Profit
- DKK -96,915
- Profit/Loss
- DKK 2,724,804
- Equity
- DKK 22,438,251
- Total Assets
- DKK 22,590,087
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ABL BIOTEC A/S has published its annual report for 2012. Gross profit came to DKK -50,503, and the net result was DKK 3,685,841.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of ABL BIOTEC A/S.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.
